What one share of Kraig Biocraft Laboratories holds
Biocraft Laboratories, Inc., a Wyoming corporation, is a corporation organized to develop high strength fibers using recombinant DNA technology for commercial applications including technical textiles. We use genetically engineered silkworms that produce spider silk proteins to create our recombinant spider silk.
Kraig Biocraft Laboratories’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.00 |
|---|---|
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.00 |
| Cash and investments | $0.00 |
| Book value | −$0.01 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2011 | $0.00 | −$0.00 | $0.00 | −$0.00 | — | −$0.00 |
| 2012 | $0.00 | −$0.00 | $0.00 | −$0.00 | — | −$0.00 |
| 2013 | $0.00 | −$0.01 | $0.00 | −$0.00 | — | −$0.00 |
| 2014 | $0.00 | −$0.00 | $0.00 | −$0.00 | — | −$0.00 |
| 2015 | $0.00 | −$0.00 | $0.00 | −$0.00 | — | −$0.00 |
| 2016 | $0.00 | −$0.00 | $0.00 | −$0.00 | — | −$0.00 |
| 2017 | $0.00 | −$0.00 | $0.00 | −$0.00 | — | −$0.00 |
| 2018 | $0.00 | −$0.00 | $0.00 | −$0.00 | — | −$0.01 |
| 2019 | — | −$0.00 | $0.00 | −$0.00 | — | −$0.01 |
| 2020 | — | −$0.01 | — | — | — | −$0.01 |
| 2021 | — | −$0.01 | $0.00 | −$0.00 | — | −$0.01 |
| 2022 | — | −$0.00 | $0.00 | −$0.00 | — | −$0.00 |
| 2023 | — | −$0.00 | $0.00 | −$0.00 | — | −$0.01 |
| 2024 | — | −$0.00 | $0.00 | −$0.00 | — | −$0.01 |
| 2025 | — | −$0.00 | $0.00 | −$0.00 | — | −$0.01 |
Common questions about Kraig Biocraft Laboratories
How much does one share of Kraig Biocraft Laboratories earn?
Over the last 12 months, Kraig Biocraft Laboratories lost $0.00 for each share.
Does Kraig Biocraft Laboratories pay a dividend?
Kraig Biocraft Laboratories didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Kraig Biocraft Laboratories’s book value per share?
Kraig Biocraft Laboratories’s book value is negative (−$0.01 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Kraig Biocraft Laboratories have?
Each share of Kraig Biocraft Laboratories has $0.00 of cash and investments, as of June 30, 2026.
What is Kraig Biocraft Laboratories’s free cash flow per share?
−$0.00 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Kraig Biocraft Laboratories bought back shares?
Kraig Biocraft Laboratories’s share count rose about 85% from 2011 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.